Friday Dec 11 | Drug Store News
Sandoz launches topical psoriasis treatment
PRINCETON,A N.J. Sandoz has launched its version of a topical drug used to treat psoriasis of the scalp, the Swiss generic drug maker announced Thursday.
FDA approves two generic versions of Leo Pharma's Dovonex
AMITYVILLE, N.Y. and FORT COLLINS, Colo. The Food and Drug Administration has approved both Hi-Tech Pharmacal's and Tolmar's generic versions of calcipotriene, the generic equivalent of Leo Pharma's Dovonex, in the .005% strength.
LEO Pharma Repurchases Product Rights From Warner Chilcott
Warner Chilcott plc and LEO Pharma announced today that, in exchange for a one-time cash payment of $1.0 billion to Warner Chilcott, LEO Pharma is re-acquiring Warner Chilcott's exclusive product licensing rights in the United States to its topical psoriasis treatments Taclonex , Taclonex Scalp , Dovonex as well as rights to all products in LEO's ...
The big picture: Phototherapy, topical combinations help improve vitiligo
Advances in phototherapy continue to give dermatologists powerful new options for the treatment of vitiligo, and while there still is no cure for the condition, phototherapy, along with creative new treatment combinations, is offering increasingly successful results.
Also on Topix